Victory Capital Management’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Other funds holding STOK
LCM
Victory Capital Management's STOK Position: Q3 2026 in Review
Victory Capital Management increased its Stoke Therapeutics (STOK) stake by 138% in Q3 2026, buying an estimated $1.87M and bringing the position to 106,973 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1566.
Victory Capital Management first reported a position in STOK in Q2 2019 and has held it in 19 quarters since. The position peaked at $5.09M in Q4 2019. 185 funds tracked by Wall St. Rank hold STOK as of Q3 2026.
- Victory Capital Management held 106,973 shares of Stoke Therapeutics worth $2.78M as of Q3 2026.
- Victory Capital Management bought 62,073 Stoke Therapeutics shares in Q3 2026, an estimated $1.87M.
- Stoke Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #1566 holding.
- Victory Capital Management first reported a position in Stoke Therapeutics in Q2 2019 and has held it in 19 quarters since.
- Victory Capital Management's Stoke Therapeutics position peaked at $5.09M in Q4 2019.
- 185 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.
Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.